InvestorsHub Logo
Followers 58
Posts 10354
Boards Moderated 1
Alias Born 09/21/2016

Re: georgejjl post# 367416

Sunday, 07/24/2022 8:33:15 PM

Sunday, July 24, 2022 8:33:15 PM

Post# of 471217
georgejji

NEXT SUNDAY

Study of the mechanism of action of Blarcamesine (ANAVEX®2-73): Whole blood transcriptomics analysis identifies treatment impact on compensatory pathways by restoring key neurodegenerative pathways functionality, including Alzheimer’s disease pathway

Virtual Platform
Sun, Jul 31
7:00am - 11:55pm (Pacific)

Author Block: Coralie Williams, MSc1; Martin Kindermans, MSC1; Frédéric Parmentier, PhD1; Federico Goodsaid, PhD1; Edward Hammond, MD, PhD, MPH2; Christopher U Missling, PhD2 and Mohammad Afshar, MD, PhD1, (1)Ariana Pharma, Paris, France, (2)Anavex Life Sciences Corp., New York, NY, USA



George...any clues on likely leaks/factoids before the conference you mention? THIS, Could result in a busy week of dubious-fudster stuff if not cautious...a little bit of /only a few lies will do a lot of harm in this environment. Hope apprpriate precautions have been taken. Go to DEFCON II .

Be careful out there.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News